ATE390136T1 - Saure chinolin-derivate und ihre verwendung zur prävention und/oder behandlung von erkrankungen im zusammenhang mit hyperglykämie - Google Patents
Saure chinolin-derivate und ihre verwendung zur prävention und/oder behandlung von erkrankungen im zusammenhang mit hyperglykämieInfo
- Publication number
- ATE390136T1 ATE390136T1 AT04803419T AT04803419T ATE390136T1 AT E390136 T1 ATE390136 T1 AT E390136T1 AT 04803419 T AT04803419 T AT 04803419T AT 04803419 T AT04803419 T AT 04803419T AT E390136 T1 ATE390136 T1 AT E390136T1
- Authority
- AT
- Austria
- Prior art keywords
- hyperglycemia
- preventing
- treating diseases
- diseases related
- quinoline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0315402A FR2864535B1 (fr) | 2003-12-24 | 2003-12-24 | Derives acides de quinoline et leurs applications en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE390136T1 true ATE390136T1 (de) | 2008-04-15 |
Family
ID=34639610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04803419T ATE390136T1 (de) | 2003-12-24 | 2004-12-01 | Saure chinolin-derivate und ihre verwendung zur prävention und/oder behandlung von erkrankungen im zusammenhang mit hyperglykämie |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7470708B2 (de) |
| EP (1) | EP1696924B1 (de) |
| JP (1) | JP4861828B2 (de) |
| KR (1) | KR20060123369A (de) |
| CN (1) | CN1893949A (de) |
| AR (1) | AR046980A1 (de) |
| AT (1) | ATE390136T1 (de) |
| AU (1) | AU2004308578B2 (de) |
| BR (1) | BRPI0417140A (de) |
| CA (1) | CA2551227C (de) |
| DE (1) | DE602004012770T2 (de) |
| ES (1) | ES2302058T3 (de) |
| FR (1) | FR2864535B1 (de) |
| MX (1) | MXPA06007082A (de) |
| RU (1) | RU2006126781A (de) |
| WO (1) | WO2005063244A1 (de) |
| ZA (1) | ZA200606065B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0506133D0 (en) * | 2005-03-24 | 2005-05-04 | Sterix Ltd | Compound |
| SG190603A1 (en) * | 2008-05-01 | 2013-06-28 | Sirtris Pharmaceuticals Inc | Quinolines and related analogs as sirtuin modulators |
| PL228037B1 (pl) * | 2009-03-23 | 2018-02-28 | Marciniak Agnieszka Maria | Zastosowanie kwasu kynureninowego w zapobieganiu lub leczeniu chorób trzustki |
| US8450369B1 (en) * | 2011-08-02 | 2013-05-28 | CIP Kemicals, Corp. | Hypoglycemic oral drug for treating non-insulin dependent and insulin dependent diabetes |
| US8877811B1 (en) | 2011-08-02 | 2014-11-04 | CIP Kemicals, Corp. | Hypoglycemic oral drug for treating non-insulin dependent and insulin dependent diabetes |
| CN115124462B (zh) * | 2022-07-22 | 2023-08-22 | 浙江工业大学 | 2,3-二甲基-6,8-二氟喹啉-4-醚类化合物及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5245046A (en) * | 1988-11-14 | 1993-09-14 | The Upjohn Company | α-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents |
| US5026700A (en) * | 1989-05-16 | 1991-06-25 | Merrell Dow Pharmaceuticals | Certain quinolines and thienopyridines as excitatory amino acid antagonists |
| ZA903588B (en) * | 1989-05-16 | 1991-02-27 | Merrell Dow Pharma | Excitatory amino acid antagonists |
| JPH03161441A (ja) * | 1989-11-20 | 1991-07-11 | Senjiyu Seiyaku Kk | メイラード反応阻害剤 |
| US5728728A (en) * | 1996-04-10 | 1998-03-17 | Kozachuk; Walter E. | Methods of providing neuroprotection |
| US6025369A (en) * | 1996-05-03 | 2000-02-15 | The Board Of Regents Of The University Nebraska | N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis |
| FR2791263B1 (fr) * | 1999-03-26 | 2001-04-27 | Halina Zofia Malina | Preparations des medicaments bases sur une reponse immunitaire contre l'accumulation de proteines modifiees par l'acide xanthurenique |
| DE10005302A1 (de) * | 2000-02-07 | 2002-01-17 | Gruenenthal Gmbh | Substituierte 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate |
| FR2827599A1 (fr) * | 2001-07-20 | 2003-01-24 | Neuro3D | Composes derives de quinoleine et quinoxaline,preparation et utilisations |
| AU2002950217A0 (en) * | 2002-07-16 | 2002-09-12 | Prana Biotechnology Limited | 8- Hydroxy Quinoline Derivatives |
| GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
-
2003
- 2003-12-24 FR FR0315402A patent/FR2864535B1/fr not_active Expired - Fee Related
-
2004
- 2004-12-01 RU RU2006126781/15A patent/RU2006126781A/ru not_active Application Discontinuation
- 2004-12-01 JP JP2006545961A patent/JP4861828B2/ja not_active Expired - Fee Related
- 2004-12-01 DE DE602004012770T patent/DE602004012770T2/de active Active
- 2004-12-01 US US10/584,151 patent/US7470708B2/en not_active Expired - Fee Related
- 2004-12-01 AT AT04803419T patent/ATE390136T1/de not_active IP Right Cessation
- 2004-12-01 ES ES04803419T patent/ES2302058T3/es active Active
- 2004-12-01 MX MXPA06007082A patent/MXPA06007082A/es not_active Application Discontinuation
- 2004-12-01 CA CA2551227A patent/CA2551227C/en not_active Expired - Fee Related
- 2004-12-01 KR KR1020067012375A patent/KR20060123369A/ko not_active Application Discontinuation
- 2004-12-01 BR BRPI0417140-3A patent/BRPI0417140A/pt not_active IP Right Cessation
- 2004-12-01 AU AU2004308578A patent/AU2004308578B2/en not_active Ceased
- 2004-12-01 WO PCT/EP2004/013662 patent/WO2005063244A1/en active IP Right Grant
- 2004-12-01 CN CNA2004800375844A patent/CN1893949A/zh active Pending
- 2004-12-01 EP EP04803419A patent/EP1696924B1/de active Active
- 2004-12-22 AR ARP040104837A patent/AR046980A1/es not_active Application Discontinuation
-
2006
- 2006-07-21 ZA ZA200606065A patent/ZA200606065B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0417140A (pt) | 2007-02-21 |
| ES2302058T3 (es) | 2008-07-01 |
| WO2005063244A1 (en) | 2005-07-14 |
| ZA200606065B (en) | 2007-12-27 |
| US20070149566A1 (en) | 2007-06-28 |
| KR20060123369A (ko) | 2006-12-01 |
| EP1696924A1 (de) | 2006-09-06 |
| EP1696924B1 (de) | 2008-03-26 |
| JP2007516986A (ja) | 2007-06-28 |
| DE602004012770T2 (de) | 2009-04-09 |
| CN1893949A (zh) | 2007-01-10 |
| JP4861828B2 (ja) | 2012-01-25 |
| RU2006126781A (ru) | 2008-01-27 |
| FR2864535B1 (fr) | 2006-12-22 |
| AR046980A1 (es) | 2006-01-04 |
| DE602004012770D1 (de) | 2008-05-08 |
| CA2551227C (en) | 2013-03-12 |
| CA2551227A1 (en) | 2005-07-14 |
| AU2004308578A1 (en) | 2005-07-14 |
| AU2004308578B2 (en) | 2010-11-11 |
| US7470708B2 (en) | 2008-12-30 |
| MXPA06007082A (es) | 2006-08-23 |
| FR2864535A1 (fr) | 2005-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60319865D1 (de) | Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen | |
| DE602004017588D1 (de) | 2-phenoxy- und 2-phenylsulfanyl-benzenesulfonamid derivate mit ccr3 antagonistischer aktivität zur behandlung von asthma und anderen entzündlichen oder immunologischen erkrankungen | |
| ATE518841T1 (de) | Herstellung und verwendung von arylalkylsäurederivaten zur behandlung von obesitas | |
| DE602005015451D1 (de) | Auf probiotischen bakterien basierende zusammensetzung und ihre verwendung zur vorbeugung und/oder behandlung von atemwegserkrankungen und/oder infektionen sowie zur verbesserung der darmtätigkeit | |
| ATE448206T1 (de) | Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen | |
| DE602005005810D1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
| DE60221627D1 (de) | Thiazolderivate und ihre Verwendung zur Behandlung oder Vorbeugung von Infektionen durch Flaviviren | |
| DE60335560D1 (de) | Zusammensetzungen enthaltend zitronensäure zur behandlung von nagelpilzerkrankungen | |
| DE602005017503D1 (de) | Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen | |
| ATE414556T1 (de) | Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten | |
| DE50306850D1 (de) | Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen | |
| ATE519488T1 (de) | Aminopyrazin-analoga zur behandlung von glaukomen und anderen durch rho-kinase verursachten krankheiten | |
| DE602006018583D1 (de) | Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten | |
| ATE499105T1 (de) | Behandlung oder vorbeugung von haut- oder gewebezuständen bei tieren unter verwendung von boryloxypyridylmethanonen | |
| DE60335293D1 (de) | Pyrrolopyridazin-verbindungen und verwendungsverfahren dafür zur behandlung von proliferativen erkrankungen | |
| DE602004022036D1 (de) | Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen | |
| DE602004002585D1 (de) | VERWENDUNG EINER PHARMAZEUTISCHEN FORMULIERUNG ENTHALTEND MILCHSÄURE ODER LAKTAT UND kALIUM ZUR BEHANDLUNG VON HIRNÖDEM UND VERLETZUNGEN DES GEHIRNS | |
| ATE542804T1 (de) | 5-phenyl-pentansäurederivate als matrixmetalloproteinase-inhibitoren zur behandlung von asthma und anderen erkrankungen | |
| ATE516040T1 (de) | Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis | |
| DE602004001134D1 (de) | Tetrazolderivate und verfahren zur behandlung von stoffwechselbedingten erkrankungen damit | |
| DE602004022035D1 (de) | Verwendung von pthalide derivativen zur behandlung | |
| DE60312505D1 (de) | Injektion aus ixeris sonchifolia zur behandlung von kardiozerebralen gefässerkrankungen und funduserkrankungen sowie herstellungsverfahren dafür | |
| ATE390136T1 (de) | Saure chinolin-derivate und ihre verwendung zur prävention und/oder behandlung von erkrankungen im zusammenhang mit hyperglykämie | |
| ATE418552T1 (de) | Substituierte amino-furan-2-yl-essigsaure- und amino-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz | |
| DE60314003D1 (de) | 4-(phenylpiperazinylmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen oder gastrointestinalen erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |